Table 1.

Baseline characteristics of patients who underwent RCs.

			RC-pentafecta achievement
	Total		No		Yes
	No./mean	%/IQR	No./mean	%/IQR	No./mean	%/IQR
Age	68	63–72	68	64–72	66	60–72	0.24
BMI (kg/m2)	25.8	22–29	25.3	22–29	26.5	24–29.5	0.19
Hemoglobin (g/dl)	12.5	10.8–13.8	12.4	10.8–13.8	13	10.6–14.3	0.36
Creatinine (mg/dl)	1.06	0.85–1.35	1.1	0.88–1.1	0.88	0.81–1.16	0.0005
Male	228	75	177	74.68	51	76.12	0.87
Hematuria	178	58.55	124	55.61	54	83.08	<0.0001
Hydronephrosis	106	34.87	88	37.13	18	26.87	0.15
ASA score
1	16	5.26	14	5.91	2	2.99	0.067
2	125	41.12	98	41.35	27	40.30
3	147	48.36	109	45.99	38	56.72
4	16	5.26	16	6.75	0	0.00
Smoking status
Active	97	36.06	80	38.83	17	26.98	0.17
Former	115	42.75	82	39.81	33	52.38
Never	57	21.19	44	21.36	13	20.63
Neoadjuvant chemotherapy	76	25.0	62	26.16	14	20.90	0.42
Preoperative cT
cT0	4	1.32	2	0.84	2	2.99	0.72
cT1	45	14.8	34	14.35	11	16.42
cT2	158	51.97	125	52.74	33	49.25
cT3	59	19.41	45	18.99	14	20.90
cT4	31	10.2	24	10.13	7	10.45
CIS	5	1.64	5	2.11	0	0.00
Ta	2	0.66	2	0.84	0	0
Preoperative cN
cN0	200	65.79	143	60.34	57	85.07	<0.0001
cN1	15	4.93	10	4.22	5	7.46
cN2	19	6.25	17	7.17	2	2.99
cN3	10	3.29	9	3.80	1	1.49
cNx	60	19.74	58	24.47	2	2.99

RC, radical cystectomy; IQR, interquartile range; ASA, American Association of Anesthesiology; CIS, carcinoma in situ.